| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 45 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $418.2K | - | |
| CFO | 26.0K | $181.2K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $56.13 | $2,168,448.64 | -0.2% | |
| Oct 17, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $52.24 | $104,480.00 | -7.1% | |
| Oct 17, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $55.02 | $2,125,871.88 | -0.3% | |
| Oct 4, 2017 | Yu K Peony | Chief Medical Officer | Sale+OE | 15,000 | $60.00 | $900,000.00 | -7.9% | |
| Oct 3, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $55.09 | $2,128,313.50 | -0.4% | |
| Oct 2, 2017 | Yu K Peony | Chief Medical Officer | Sale+OE | 40,000 | $54.63 | $2,185,000.00 | -9.5% | |
| Sep 20, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $53.46 | $2,065,485.45 | -0.4% | |
| Sep 18, 2017 | Kurkijarvi Kalevi | Director | Sell | 4,000 | $46.65 | $186,580.00 | -6.5% | |
| Sep 14, 2017 | Yu K Peony | Chief Medical Officer | Sell | 2,851 | $51.00 | $145,401.00 | -1.5% | |
| Sep 14, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $51.67 | $1,996,273.85 | -0.2% |